Pancreatic Cancer Research

ResearcherGhent University HospitalActive in the last 2 years

Filip Gryspeerdt

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-0802-8446; OpenAlex author ID A5055156828. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 3 papers · 2026: 1 paper

Papers 5

  1. Success rate of salvage neoadjuvant chemotherapy for unexpectedly identified locally advanced pancreatic ductal adenocarcinoma during surgical exploration. Co-author DOI 10.1016/j.hpb.2025.10.003↗
  2. Routine Imaging or Symptomatic Follow-Up After Resection of Pancreatic Adenocarcinoma. Co-author DOI 10.1001/jamasurg.2024.5024↗
  3. Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRFormanCe): a multicente… First author DOI 10.1186/s12893-025-02938-1↗
  4. Use of Irreversible Electroporation in Pancreatic Cancer Patients: A Multi-Center Experience. Co-author DOI 10.3390/curroncol32100574↗
  5. Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two different entities? First author DOI 10.1186/s12893-023-02200-6↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Frederik Christiaan Berrevoet · 4 shared papers, 2023–2026 · strength 0.97
  2. L.F. Abreu de Carvalho · 3 shared papers, 2023–2026 · strength 0.72
  3. Karen Paula Geboes · 2 shared papers, 2025–2026 · strength 0.53
  4. Geert Roeyen · 1 shared paper, 2025 · strength 0.25
  5. Bart Hendrikx · 1 shared paper, 2025 · strength 0.25
  6. Nele Vandenbussche · 1 shared paper, 2025 · strength 0.20
  7. Kathleen Claes · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.